Comparison of the predictive abilities of pharmacogenetics-based warfarin dosing algorithms using seven mathematical models in Chinese patients

Genetic variants associated with warfarin dose in African-American individuals: a genome-wide association study

(2013) Minoli A Perera et al.   LANCET

Improvement of Adequate Use of Warfarin for the Elderly Using Decision Tree-based Approaches

(2013) K. E. Liu et al.   METHODS OF INFORMATION IN MEDICINE

A Randomized Trial of Genotype-Guided Dosing of Acenocoumarol and Phenprocoumon

(2013) Talitha I. Verhoef et al.   NEW ENGLAND JOURNAL OF MEDICINE

A Pharmacogenetic versus a Clinical Algorithm for Warfarin Dosing

(2013) Stephen E. Kimmel et al.   NEW ENGLAND JOURNAL OF MEDICINE

A Randomized Trial of Genotype-Guided Dosing of Warfarin

(2013) Munir Pirmohamed et al.   NEW ENGLAND JOURNAL OF MEDICINE

Prediction of optimal warfarin maintenance dose using advanced artificial neural networks

(2013) Enzo Grossi et al.   PHARMACOGENOMICS

High-dimensional pharmacogenetic prediction of a continuous trait using machine learning techniques with application to warfarin dose prediction in African Americans

(2011) Erdal Cosgun et al.   BIOINFORMATICS

VKORC1 and CYP2C9 genotype and patient characteristics explain a large proportion of the variability in warfarin dose requirement among children

(2011) T. T. Biss et al.   BLOOD

Dosing equation for tacrolimus using genetic variants and clinical factors

(2011) Chaitali Passey et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Loading and maintenance dose algorithms for phenprocoumon and acenocoumarol using patient characteristics and pharmacogenetic data

(2011) Rianne M.F. van Schie et al.   EUROPEAN HEART JOURNAL

Comparison of warfarin pharmacogenetic dosing algorithms in a racially diverse large cohort

(2010) Jaekyu Shin et al.   PHARMACOGENOMICS

Estimation of the Warfarin Dose with Clinical and Pharmacogenetic Data

(2009)   NEW ENGLAND JOURNAL OF MEDICINE

Effect of CYP2C9 and VKORC1 genotypes on early-phase and steady-state warfarin dosing in Korean patients with mechanical heart valve replacement

(2009) Ho-Sook Kim et al.   Pharmacogenetics and Genomics

A Genome-Wide Association Study Confirms VKORC1, CYP2C9, and CYP4F2 as Principal Genetic Determinants of Warfarin Dose

(2009) Fumihiko Takeuchi et al.   PLoS Genetics

The largest prospective warfarin-treated cohort supports genetic forecasting

(2008) M. Wadelius et al.   BLOOD

Use of Pharmacogenetic and Clinical Factors to Predict the Therapeutic Dose of Warfarin

(2008) BF Gage et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS